Pervasis Therapeutics

M. T.
October 2007
Red Herring;10/7/2007, Vol. 4 Issue 29, p73
Trade Publication
The article features Pervasis Therapeutics, a biosciences company included in "Red Herring's" top 100 list for 2007. The company is based in Cambridge, Massachusetts. It was founded in 2003. Its chief executive officer (CEO) is Stephen Bollinger. Among its key investors are Flagship Venture Partners, Highland Venture Partners and Polaris Venture Partners. Pervasis is developing an alternative treatment called Vascugel, a gel made of engineered human tissue that is wrapped around injured blood vessels to promote healing and prevent scar tissue from forming.


Related Articles

  • The Use of DC Electrodermal Potential Measurements and Healer's Felt Sense to Assess the Energetic Nature of Qi. Syldona, Maria; Rein, Glen // Journal of Alternative & Complementary Medicine;Aug1999, Vol. 5 Issue 4, p329 

    Describes the direct current electrodermal potential measurements assessment method for the scientific study of energy healing arts practitioners. Discussion on energy and the sciences of life; Experimental data illustrating how the technique may provide insight into the mechanisms of energy...

  • Pervasis Tackling PAD with $17M Round; Seeks Vascugel Partner. Boggs, Jennifer // BioWorld Today;9/17/2009, Vol. 20 Issue 179, p1 

    The article reports on the move by Cambridge, Massachusetts-based Pervasis Therapeutics Inc. to secure a 17 million dollars in venture funding to finance work on a second-level development candidate for its endothelial technology. It explains that the company is also seeking a partner for its...

  • Pervasis Gets $9.75M for Blood Vessel Product.  // Bioworld Week;1/21/2008, Vol. 16 Issue 3, p4 

    The article reports that Pervasis Therapeutics Inc. in Cambridge, Massachusetts raised $9.75 million to support the Phase II development of its Vascugel blood vessel repair product and to conduct research on expanding the product's uses. The company completed patient enrollment for its two Phase...

  • Product pipeline.  // Cardiovascular Device Update;Oct2007, Vol. 13 Issue 10, p35 

    The article reports on the publication of animal data for Cambridge, Massachusetts-based Pervasis Therapeutics' Vascugel product under investigation to aid in healing, function, and remodeling of traumatized veins and arteries. The product is a biologically active matrix of endothelial cells...

  • Pervasis Tackling PAD with $17M Round.  // Bioworld Week;9/21/2009, Vol. 17 Issue 38, p4 

    The article reports on the new venture entered by Pervasis Therapeutics Inc. for the Phase II of its studies on peripheral arterial disease (PAD) in Cambridge, Massachusetts. It states that Pervasis has padded its bank account to seek partners for its Vascugel program and for the special...

  • Best Practices' Chain Reaction: Chiropractic Best Practices: Not Fear, Just Facts. Whalen, Wayne M.; Lewis, Eugene A. // American Chiropractor;Aug2006, Vol. 28 Issue 9, p51 

    The article reports on the objectives and purposes of the "Best Practice" document made by the Council on Chiropractic Guidelines and Practice Parameters (CCGPP). CCGPP "Best Practice" document aims to give providers, patients, and stakeholders a library of evidence concerning chiropractic care....

  • Peeping out of the science room. Fuller, Will // Biologist;Apr2004, Vol. 51 Issue 1, p4 

    In this article , the author talks about complementary and alternative medicine (CAM). He says there is a lot in it for science. New science lives on the edge, and scientists have always got into trouble for challenging orthodoxy. Perhaps people need that enthusiasm which creates as its...

  • Alternative Medicine: Guide to Critical Analysis.  // Points of View: Alternative Medicine;3/1/2016, p4 

    This article offers a critical guide to the controversial issue of alternative medicine. The article discusses criteria in understanding the issue, such as distinguishing between fact and opinion and recognizing point and counterpoint arguments. Also presented are exercises that help the reader...

  • AN INVESTIGATION OF THE CONTENTS OF COMPLEMENTARY AND ALTERNATIVE MEDICINE JOURNALS. Coelho, Helen F.; Pittler, Max H.; Ernst, Edzard // Alternative Therapies in Health & Medicine;Jul/Aug2007, Vol. 13 Issue 4, p40 

    Context • Previous research suggests that complementary and alternative medicine (CAM) journals publish few clinical trials, systematic reviews, and meta-analyses and a high proportion of positive articles. Objective • This study describes the content of major CAM journals in 2005...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics